Lilly has announced a significant expansion of its manufacturing presence in Ireland, with a $1bn investment earmarked for ...

Oncternal is halting the development of two cancer candidates, ONCT-534 and ONCT-808, after disappointing trial results.

Sobi and Enable Injections have entered an agreement for the development and distribution of Aspaveli in combination with ...

R&D frameworks are in place for the next pandemic-causing pathogen, but ways to derisk development are unclear.

The company plans to focus its resources on conducting clinical trials for CD388 influenza prevention therapy.

Moderna will slash five clinical programmes but says it remains on track for ten product approvals in the next three years.

Sanofi has signed a licensing agreement with RadioMedix and Orano Med to advance a radioligand therapy, AlphaMedix.

The data from two Phase III trials demonstrated GLP-1/glucagon agonist’s efficacy in reducing blood glucose and weight.

The US Food and Drug Administration (FDA) has approved Roche's Tecentriq Hybreza, a subcutaneous anti-PD-(L)1 cancer ...

Johnson & Johnson has announced that the US FDA has approved TREMFYA for the treatment of active ulcerative colitis (UC).

India's CDSCO has suspended the license of Entod Pharmaceuticals’ PresVu eye drops due to safety concerns and unauthorised ...

Gilead Sciences has partnered with Genesis Therapeutics to discover and develop new small molecule therapies using AI.